| Literature DB >> 25612113 |
Patricia M R Pereira1, Barbara Korsak, Bruno Sarmento, Rudolf J Schneider, Rosa Fernandes, João P C Tomé.
Abstract
Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able to recognize and bind to tumor-associated antigens, is today one of the most attractive strategies in photodynamic therapy (PDT). This comprehensive review updates on chemical routes available for the preparation of photo-immunoconjugates (PICs), which show dual chemical and biological functionalities: photo-properties of the photosensitizer and the immunoreactivity of the antibody. Moreover, photobiological results obtained with such photo-immunoconjugates using in vitro and in vivo cancer models are also discussed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25612113 DOI: 10.1039/c4ob02334j
Source DB: PubMed Journal: Org Biomol Chem ISSN: 1477-0520 Impact factor: 3.876